(Q44011159)

28 November 2017

title

Relationship between pharmacokinetics and hemodynamic tolerance to isosorbide-5-mononitrate (English)

1 reference

28 November 2017

1 reference

1 reference

F Wagner

1

1 reference

28 November 2017

F Siefert

series ordinal

2

1 reference

28 November 2017

D Trenk

series ordinal

3

1 reference

28 November 2017

E Jähnchen

series ordinal

4

1 reference

28 November 2017

publication date

1 January 1990

1 reference

European Journal of Clinical Pharmacology

28 November 2017

published in

1 reference

28 November 2017

volume

38 Suppl 1

1 reference

28 November 2017

page(s)

S53-9

1 reference

Tolerance to organic nitrates

28 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01417565

Nitrate therapy without loss of action by correct dosage

21 January 2018

1 reference

12 December 2020

Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris

1 reference

12 December 2020

[Nitrate tolerance: pro and con]

1 reference

12 December 2020

Nitrate therapy in stable angina pectoris

1 reference

12 December 2020

Characteristic pulse wave caused by organic nitrates.

1 reference

12 December 2020

Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy

1 reference

12 December 2020

Difference in nitroglycerin dose-response in the venous and arterial beds.

1 reference

12 December 2020

Blood vessel uptake and metabolism of organic nitrates in the rat.

1 reference

12 December 2020

[Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine]

1 reference

12 December 2020

Induction and circumvention of nitrate tolerance applying different dosage intervals

1 reference

12 December 2020

Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates

1 reference

12 December 2020

[Continuing anti-anginal effectiveness during chronic nitrate therapy in spite of the cessation of hemodynamic partial effects]

1 reference

12 December 2020

Tolerance to isosorbide dinitrate: rate of development and reversal

1 reference

12 December 2020

Tolerance development during isosorbide dinitrate treatment: can it be circumvented?

1 reference

12 December 2020

Nitroglycerin and afterload: effects of aortic compliance and capacity of the Windkessel.

1 reference

12 December 2020

Biotransformation of Isosorbide Dinitrate in Humans

1 reference

12 December 2020

Effect of intervals between doses on the development of tolerance to isosorbide dinitrate

1 reference

12 December 2020

Measurement of arterial and venous reactivity by an advanced strain gauge plethysmograph

1 reference

12 December 2020

[Long term therapy of coronary heart disease with 120 mg slow release isosorbide dinitrate once a day. Study of duration of action and development of tolerance]

1 reference

12 December 2020

Pharmacokinetics of intravenous and oral isosorbide-5-mononitrate

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01417565

1 reference

28 November 2017

1 reference